Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Scalp cooling effectively reduces hair loss from chemotherapy.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Astragaloside IV may help prevent hair loss by blocking a specific pathway that leads to cell death.

Lespedeza bicolor extract promotes hair growth and increases hair follicle cell growth, potentially making it a better treatment than minoxidil.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Metformin may help treat neuroendocrine tumors.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.